Scott B. Baver

764 total citations
16 papers, 573 citations indexed

About

Scott B. Baver is a scholar working on Molecular Biology, Immunology and Endocrine and Autonomic Systems. According to data from OpenAlex, Scott B. Baver has authored 16 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Immunology and 5 papers in Endocrine and Autonomic Systems. Recurrent topics in Scott B. Baver's work include Complement system in diseases (6 papers), Renal Diseases and Glomerulopathies (3 papers) and Regulation of Appetite and Obesity (3 papers). Scott B. Baver is often cited by papers focused on Complement system in diseases (6 papers), Renal Diseases and Glomerulopathies (3 papers) and Regulation of Appetite and Obesity (3 papers). Scott B. Baver collaborates with scholars based in United States, France and Italy. Scott B. Baver's co-authors include Gary E. Pickard, Patricia J. Sollars, Galen Pickard, Kristen M.S. O’Connell, Christian Bjørbæk, Catherine C. Kaczorowski, Kevin A. Hope, Martin Kolev, Pascal Deschatelets and Mindy Leelawong and has published in prestigious journals such as Journal of Neuroscience, Blood and PLoS ONE.

In The Last Decade

Scott B. Baver

16 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott B. Baver United States 9 374 217 193 90 72 16 573
Irène Cimino United Kingdom 10 277 0.7× 235 1.1× 81 0.4× 157 1.7× 95 1.3× 15 905
Daniel J. Trombly United States 11 376 1.0× 284 1.3× 70 0.4× 194 2.2× 206 2.9× 11 788
Hong Cui United States 14 178 0.5× 279 1.3× 125 0.6× 64 0.7× 70 1.0× 19 624
Carla Brancia Italy 15 121 0.3× 183 0.8× 158 0.8× 128 1.4× 69 1.0× 22 531
William C. Krause United States 13 108 0.3× 194 0.9× 180 0.9× 65 0.7× 18 0.3× 14 599
W Klootwijk Netherlands 18 264 0.7× 169 0.8× 186 1.0× 111 1.2× 108 1.5× 35 854
Nicola Romanò United Kingdom 15 111 0.3× 271 1.2× 98 0.5× 64 0.7× 10 0.1× 34 804
Sophie Croizier France 13 309 0.8× 139 0.6× 57 0.3× 150 1.7× 100 1.4× 25 595
Åsa Larefalk Sweden 7 184 0.5× 150 0.7× 143 0.7× 199 2.2× 76 1.1× 10 572
Yoshihiro Tokugawa Japan 16 114 0.3× 217 1.0× 155 0.8× 32 0.4× 21 0.3× 31 910

Countries citing papers authored by Scott B. Baver

Since Specialization
Citations

This map shows the geographic impact of Scott B. Baver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott B. Baver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott B. Baver more than expected).

Fields of papers citing papers by Scott B. Baver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott B. Baver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott B. Baver. The network helps show where Scott B. Baver may publish in the future.

Co-authorship network of co-authors of Scott B. Baver

This figure shows the co-authorship network connecting the top 25 collaborators of Scott B. Baver. A scholar is included among the top collaborators of Scott B. Baver based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott B. Baver. Scott B. Baver is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Crawford, Thomas O., John Day, Darryl C. De Vivo, et al.. (2024). Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study. Frontiers in Neurology. 15. 1419791–1419791. 5 indexed citations
2.
Pokrzywinski, Robin, Hemal Shah, Nathalie Kertesz, et al.. (2023). Treatment Effects Among Patients with Type 2 and Type 3 SMA Directly Reported by Patients and Caregivers from the TOPAZ Clinical Trial (P2-8.010). Neurology. 100(17_supplement_2). 1 indexed citations
3.
Kolev, Martin, Madhumita Das, Monica Gerber, et al.. (2022). Inside-Out of Complement in Cancer. Frontiers in Immunology. 13. 931273–931273. 29 indexed citations
4.
Kolev, Martin, et al.. (2022). With complements: C3 inhibition in the clinic. Immunological Reviews. 313(1). 358–375. 24 indexed citations
5.
Bhak, Rachel H., Nikita Mody‐Patel, Scott B. Baver, et al.. (2021). Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison. Current Medical Research and Opinion. 37(11). 1913–1923. 15 indexed citations
6.
Mody‐Patel, Nikita, Scott B. Baver, Christopher Yee, et al.. (2020). Comparative Effectiveness of Pegcetacoplan Versus Ravulizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria Previously Treated with Eculizumab: A Matching-Adjusted Indirect Comparison. Blood. 136(Supplement 1). 37–38. 1 indexed citations
7.
8.
Risitano, Antonio M., Ilene C. Weitz, Carlos M. de Castro, et al.. (2020). Categorized Hematologic Response to Pegcetacoplan Versus Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Post Hoc Analysis of Data from a Phase 3 Randomized Trial (PEGASUS). Blood. 136(Supplement 1). 44–45. 1 indexed citations
9.
Argente, Jesús, et al.. (2019). Clinical characteristics of human POMC, PCSK1, and LEPR deficiencies. Endocrine Abstracts. 1 indexed citations
10.
Baver, Scott B., et al.. (2014). Leptin Modulates the Intrinsic Excitability of AgRP/NPY Neurons in the Arcuate Nucleus of the Hypothalamus. Journal of Neuroscience. 34(16). 5486–5496. 148 indexed citations
11.
Baver, Scott B., Lihong Huo, Wenjing Li, et al.. (2013). Somato-Dendritic Localization and Signaling by Leptin Receptors in Hypothalamic POMC and AgRP Neurons. PLoS ONE. 8(10). e77622–e77622. 30 indexed citations
12.
13.
14.
Pickard, Gary E., Scott B. Baver, Malcolm D. Ogilvie, & Patricia J. Sollars. (2009). Light-Induced Fos Expression in Intrinsically Photosensitive Retinal Ganglion Cells in Melanopsin Knockout (Opn4−/−) Mice. PLoS ONE. 4(3). e4984–e4984. 24 indexed citations
15.
Sollars, Patricia J., et al.. (2009). A Herpesvirus Encoded Deubiquitinase Is a Novel Neuroinvasive Determinant. PLoS Pathogens. 5(4). e1000387–e1000387. 37 indexed citations
16.
Baver, Scott B., Galen Pickard, Patricia J. Sollars, & Gary E. Pickard. (2008). Two types of melanopsin retinal ganglion cell differentially innervate the hypothalamic suprachiasmatic nucleus and the olivary pretectal nucleus. European Journal of Neuroscience. 27(7). 1763–1770. 238 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Irène Cimino Breakdown of academic impact, for papers by Daniel J. Trombly Breakdown of academic impact, for papers by Hong Cui Breakdown of academic impact, for papers by Carla Brancia Breakdown of academic impact, for papers by William C. Krause Breakdown of academic impact, for papers by W Klootwijk Breakdown of academic impact, for papers by Nicola Romanò Breakdown of academic impact, for papers by Sophie Croizier Breakdown of academic impact, for papers by Åsa Larefalk Breakdown of academic impact, for papers by Yoshihiro Tokugawa
Rankless by CCL
2026